These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22228205)

  • 1. Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.
    Chen G; Giambrone NE; Lazarus P
    Pharmacogenet Genomics; 2012 Mar; 22(3):183-90. PubMed ID: 22228205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.
    Chen G; Giambrone NE; Dluzen DF; Muscat JE; Berg A; Gallagher CJ; Lazarus P
    Cancer Res; 2010 Oct; 70(19):7543-52. PubMed ID: 20876810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
    Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
    PLoS One; 2013; 8(8):e70938. PubMed ID: 23936477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants.
    Erickson-Ridout KK; Zhu J; Lazarus P
    Pharmacogenet Genomics; 2011 Sep; 21(9):539-51. PubMed ID: 21750471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism.
    Chen G; Blevins-Primeau AS; Dellinger RW; Muscat JE; Lazarus P
    Cancer Res; 2007 Oct; 67(19):9024-9. PubMed ID: 17909004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics.
    Sun D; Chen G; Dellinger RW; Sharma AK; Lazarus P
    Pharmacogenet Genomics; 2010 Oct; 20(10):575-85. PubMed ID: 20697310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.
    Wassenaar CA; Conti DV; Das S; Chen P; Cook EH; Ratain MJ; Benowitz NL; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):94-104. PubMed ID: 25277794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines.
    Chen G; Dellinger RW; Gallagher CJ; Sun D; Lazarus P
    Pharmacogenet Genomics; 2008 Mar; 18(3):181-91. PubMed ID: 18300939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
    Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
    Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
    Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
    Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.
    Balliet RM; Chen G; Gallagher CJ; Dellinger RW; Sun D; Lazarus P
    Cancer Res; 2009 Apr; 69(7):2981-9. PubMed ID: 19318555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.
    Gallagher CJ; Balliet RM; Sun D; Chen G; Lazarus P
    Drug Metab Dispos; 2010 Dec; 38(12):2204-9. PubMed ID: 20810538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
    Perez-Paramo YX; Watson CJW; Chen G; Thomas CE; Adams-Haduch J; Wang R; Khor CC; Koh WP; Nelson HH; Yuan JM; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):54-65. PubMed ID: 36252563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.
    Taghavi T; St Helen G; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2017 Apr; 27(4):143-154. PubMed ID: 28178031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Phenotypically Poor Metabolizer Individual Donor Human Liver Microsomes To Identify Selective Substrates of UGT2B10.
    Milani N; Qiu N; Molitor B; Badée J; Cruciani G; Fowler S
    Drug Metab Dispos; 2020 Mar; 48(3):176-186. PubMed ID: 31839590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
    Wiener D; Fang JL; Dossett N; Lazarus P
    Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.